ORG-201745 is a progestin which was originated by Organon and was under development by Schering-Plough (which acquired Organon in 2007) for the treatment of "female genital diseases" and as a hormonal contraceptive for the prevention of pregnancy but was never marketed.[1]
| Clinical data | |
|---|---|
| Drug class | Progestin; Progestogen |
| Identifiers | |
| CAS Number | |
| PubChem SID | |
References
edit- ^ "ORG 201745 - AdisInsight". adisinsight.springer.com.
 | This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it. |